✦ LIBER ✦

954 BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN

✍ Scribed by G. Kukolj; Y. Benhamou; M.P. Manns; M. Bourlière; S. Pol; M. Schuchmann; M. Cartier; D. Huang; L. Lagacé; G. Steinmann; J.O. Stern

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potency, safety, and pharmacokinetics of

✍ Michael P. Manns; Marc Bourlière; Yves Benhamou; Stanislas Pol; Maurizio Bonacin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Cross-species absorption, metabolism, di

✍ Duan, Jianmin; Yong, Chan-Loi; Garneau, Michel; Amad, Ma’an; Bolger, Gordon; De 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 771 KB

63 CHARACTERIZATION OF VIROLOGIC ESCAPE

✍ F. McPhee; D. Hernandez; F. Yu; J. Ueland; C. Wang; H. Huang; D. Gardiner; R. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Characterization of vaniprevir, a hepati

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

13 COMBINATION OF THE NS5A INHIBITOR, GS

✍ Everson, G.T.; Di Bisceglie, A.M.; Vierling, J.M.; Hsieh, F.; Trenkle, J.D.; Kan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

1208 EVALUATION OF NS3 AMINO ACID VARIAN

✍ Strizki, J.M.; Barnard, R.J.O.; Cheney, C.; McHale, C.; Graham, D.; Himmelberger 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB